)
Vladimir Jankovic
Head, Translational and Precision Medicine, Immuno-Oncology,
Teva Pharmaceuticals
Translational and early clinical development scientist with >15 years of industry immuno-oncology development. Scientific and development background in immunology, hematology, oncology, cellular and antibody-based therapy (native mAb, bi-specifics, CAR, immune-targeted therapeutic payload constructs). Expertise in clinical biomarker development, PK/PD, proof of mechanism, biomarker based oncology endpoints. Broad knowledge of current and emerging clinical IO therapy landscape across solid and hematologic malignancy. Currently leading Precision medicine strategy team in a large biopharmaceutical organization.